Scientific publications
GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model
Sep 20, 2024
| Magazine: Translational Neurodegeneration
Didio Alberto Ortiz # 1, Nuria Peregrín # 1, Miguel Valencia 2 3 4, Rodrigo Vinueza-Gavilanes 1 4, Elisa Marín-Ordovas 5, Roberto Ferrero 1 4, María Jesús Nicolás 2 4, Gloria González-Aseguinolaza 1 4, Montserrat Arrasate # 6 7 8 9 10, Tomás Aragón # 11 12
Abstract
No abstract available
CITA DEL ARTÍCULO Transl Neurodegener. 2024 Sep 20;13(1):49. doi: 10.1186/s40035-024-00441-w.

Our authors

Rodrigo Vinueza Gavilanes
Laboratory technician
Gene Therapy in Neurological Diseases Research Group

Roberto Ferrero Laborda
Laboratory technician
Grupo de Investigación de Regulación de la Expresión Génica
Researcher | Principal Investigator
Advanced Therapies for Rare Liver Diseases Research Group
Researcher | Principal Investigator
Physiological Control and Monitoring Research Group